News

Monday January 29, 2018

29 Jan 2018 – $1bn rewards proposed at Davos 2018 for new antibiotics

A high-profile consortium, DRIVE-AB, has published a study in the wake of this announcement recommending broad incentives to promote antibiotic innovation and the sustainable use of the resulting, novel antibiotics […]

Tuesday January 9, 2018

09 Jan 2018 – Equity Development initiates coverage of Destiny Pharma

Equity Development today initiated coverage of Destiny Pharma by publishing a research piece by Analyst Emma Ulker entitled “In a class of its own”.  The research can be found here […]